Global Influenza Vaccines Market: Insights, Trends, Opportunities, and Outlook to 2027



DPI Research analysts predict: The number of persons being vaccinated with influenza vaccines worldwide will touch the figure of 500 Million by the year-end of 2027.

Press Release

Amazon Music Disney Promo

A new market intelligence report released by DPI Research with the title “Global Influenza Vaccines Market 2021 – 2027” is designed to cover micro-level analysis by manufacturers and key business segments. The Global Influenza Market analysis offers active visions to conclude and study the market size, trends, growth, demand, revenue, market share by company, and competitive backgrounds. This report also provides SWOT Analysis with potential market opportunities for assessing the Overall Market, underlining opportunities, and supporting strategic and tactical decision-making for companies and individuals. Some of the key players profiled in the study are Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited), AstraZeneca, Mylan, BioDiem, Novavax, Medicago, Moderna Inc, Pneumagen, Daiichi–Sankyo, Altimmune, FluGen, Imutex, EpiVax, Versatope Therapeutics, Inc., Gamma Vaccines Pty Ltd., BiondVax Pharmaceuticals Ltd., Hualan Biological Engineering Inc., Shanghai Institute of Biological Products Co., Ltd.

Long–term Growth Projection:

The global influenza vaccines market size is set to surpass US$ 6.5 Billion by the year-end of 2021

Influenza vaccines demand is expected to increase in the forecast period

The United States influenza vaccines market is projected to grow with a significant CAGR in the forecast period

In Japan, the influenza vaccines market holds a rewarding growth opportunity for the future as the demand for the vaccine is growing significantly

The Chinese influenza vaccines market is expected to record a value of nearly US$ 180 Million by the year-end of 2027

Europe is anticipated to be the fastest-growing market during the forecast period

The United Kingdom and Germany are the leading revenue generators of the market

Emerging players backed by technological advancements are developing vaccines that offer a more realistic experience

For More Information@

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at [email protected]

Contact Us:
Maria Rai
Head of Business Development
DPI Research

Direct Line: +91-766-764-8693
E-mail: [email protected]